Copy For Citation
Sezer S., Tutal E., Bal Z., Uyar M. E., Bal U., Cakir Ü., ...More
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, vol.37, no.2, pp.118-125, 2014 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
37
Issue:
2
-
Publication Date:
2014
-
Doi Number:
10.5301/ijao.5000289
-
Journal Name:
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.118-125
-
Keywords:
Hemodialysis, Secondary hyperparathyroidism, Left ventricular hypertrophy, CARDIOVASCULAR-DISEASE, PARATHYROID-HORMONE, INTESTINAL CALCIUM, DIALYSIS PATIENTS, CALCITRIOL, RISK, PARICALCITOL, CALCIFICATION, PHOSPHORUS
-
Acibadem Mehmet Ali Aydinlar University Affiliated:
Yes
Abstract
Purpose: Secondary hyperparathyroidism (SHPT) is a common feature in maintenance hemodialysis (MHD) patients. Inadequate treatment of SHPT has been associated with cardiovascular complications, and vitamin D therapy might influence the development of cardiovascular diseases. In the present study, we aimed to evaluate the effects of intravenous paricalcitol and calcitriol treatments on left ventricular mass index changes in MHD patients.